Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
COVID-19: immunopathogenesis and Immunotherapeutics
L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
Mechanistic insights into the immune pathophysiology of COVID-19; an in-depth review
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which causes
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
Cellular and humoral immune responses in covid-19 and immunotherapeutic approaches
A Hasan, E Al-Ozairi, Z Al-Baqsumi… - ImmunoTargets and …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (Covid-19), caused by the novel coronavirus severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from …
Immune responses in mildly versus critically ill COVID-19 patients
H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …
devastating effects on the global health and economic system. The cellular and molecular …
Immune response, inflammation, and the clinical spectrum of COVID-19
LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …
extended to become a global sanitary and economic emergency. Its etiological agent is the …
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
Cell-mediated immune responses to COVID-19 infection
A Guihot, E Litvinova, B Autran, P Debré… - Frontiers in …, 2020 - frontiersin.org
An unprecedented outbreak of pneumonia caused by a novel coronavirus (CoV),
subsequently termed COVID-19 by the World Health Organization, emerged in Wuhan City …
subsequently termed COVID-19 by the World Health Organization, emerged in Wuhan City …